These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3177431)

  • 1. Efficacy of antimalarials in systemic lupus erythematosus.
    Rothfield N
    Am J Med; 1988 Oct; 85(4A):53-6. PubMed ID: 3177431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of antimalarials in systemic lupus erythematosus.
    Rudnicki RD; Gresham GE; Rothfield NF
    J Rheumatol; 1975 Sep; 2(3):323-30. PubMed ID: 1102684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of antimalarials in systemic lupus erythematosus.
    Esdaile JM
    Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of antimalarials in systemic lupus erythematosus.
    Nayak V; Esdaile JM
    Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.
    Rahman P; Gladman DD; Urowitz MB; Yuen K; Hallett D; Bruce IN
    J Rheumatol; 1999 Feb; 26(2):325-30. PubMed ID: 9972966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease characterization of systemic lupus erythematosus (SLE) patients in Quebec.
    Ng R; Bernatsky S; Rahme E
    Lupus; 2017 Aug; 26(9):1005-1011. PubMed ID: 28178878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.
    Meinão IM; Sato EI; Andrade LE; Ferraz MB; Atra E
    Lupus; 1996 Jun; 5(3):237-41. PubMed ID: 8803897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    Pakchotanon R; Gladman DD; Su J; Urowitz MB
    J Rheumatol; 2018 Jan; 45(1):90-94. PubMed ID: 29142038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
    Rossoni C; Bisi MC; Keiserman MW; Staub HL
    Rev Bras Reumatol; 2011; 51(4):383-4, 386-7. PubMed ID: 21779713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antimalarial agents in the treatment of SLE and lupus nephritis.
    Lee SJ; Silverman E; Bargman JM
    Nat Rev Nephrol; 2011 Oct; 7(12):718-29. PubMed ID: 22009248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
    Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL
    Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
    Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
    Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
    Keeling SO; Bissonauth A; Bernatsky S; Vandermeer B; Fortin PR; Gladman DD; Peschken C; Urowitz MB
    J Rheumatol; 2018 Oct; 45(10):1440-1447. PubMed ID: 30068762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarials in the treatment of systemic lupus erythematosus: a registry-based cohort study in Denmark.
    Nørgaard JC; Stengaard-Pedersen K; Nørgaard M; de Thurah A
    Lupus; 2015 Mar; 24(3):299-306. PubMed ID: 25318969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimalarial drugs inhibit IFNα-enhanced TNFα and STAT4 expression in monocytes: implication for systemic lupus erythematosus.
    López P; Rodríguez-Carrio J; Suárez A
    Cytokine; 2014 May; 67(1):13-20. PubMed ID: 24680477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panniculitis and systemic lupus erythematosus.
    Winkelmann RK
    JAMA; 1970 Jan; 211(3):472-5. PubMed ID: 5466921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.